Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Revenue by Product

Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	2016 - 2018
Pharmaceuticals	2.09B	Log In	Log In	Log In	Log In	Upgrade
Pharmaceuticals Growth	-11.83%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	2016 - 2018
India	2.09B	Log In	Log In	Log In	Log In	Upgrade
India Growth	-11.83%	Log In	Log In	Log In	Log In	Upgrade